References
Ory SJ: Clinical uses of luteinizing hormone-releasing hormone. Fertil Steril 1983;39:577–591
Porter RN, Smith W, Craft IL, Abdulwalid NA, Jacob HS: Induction of ovulation for in vitro fertilization using buserelin and gonadotropins. Lancet 1984;2:1284–1285
McBain J, Trounson A: Patient management—treatment cycle.In Clinical In Vitro Fertilization, C Wood, A Trounson (eds). New York, Springer-Verlag, 1983, pp 55–61
Barnes B, Scommegna A, Scheiber J: Decreased ovarian response to human gonadotropin caused by subcutaneously administered gonadotropin-releasing hormone agonist. Fertil Steril 1987;47:512–515
Fleming R, Haxton MJ, Hamilton MPR: Successful treatment of infertile women with oligomenorrhoea using a combination of LHRH agonist and exogenous gonadotropins. Br J Obstet Gynaecol 1985;92:369
Tureck R, Mastroianni L Jr, Blasco L, Strauss JF III: Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1982;54:1078
Sheehan KL, Casper RF, Yen SSC: Luteal phase defects induced by an agonist of luteinizing hormone releasing factor: A model for fertility control. Science 1980;215:170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrier, A.J., Berkeley, A.S. & Cholst, I.N. Pretreatment with a subcutaneous gonadotropin-releasing hormone agonist in an in vitro fertilization cycle resulting in a viable pregnancy. J Assist Reprod Genet 5, 234–236 (1988). https://doi.org/10.1007/BF01131128
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01131128